Role of genetic factors and biomarkers in congenital heart defects and neurodevelopmental outcomes
726 views · Published 22 June 2018 · 21:40 · Indexed 16 November 2026
Channel: Michigan Medicine · 2018 · Education
Learn the latest insights on the influence of genetic factors and biomarkers on neurodevelopmental outcomes of children with congenital heart disorders. Mark Russell, MD, pediatric cardiologist with U-M C.S. Mott Children’s Hospital’s Congenital Heart Center, discusses the role of biomarkers and influence of genetics on neurodevelopmental outcomes for individuals with CHDs. Presented at the 6th Annual Cardiac Neurodevelopmental Symposium in June 2017. C.S. Mott Children’s Hospital is consistently ranked among the nation’s top congenital heart programs in the nation. In 2017, U.S. News & World Report ranked C.S. Mott Children’s Hospital the #3 program in the United States. Learn more at http://www.mottchildren.org/congenital
More from this channel
-
2:21
Breast cancer and osteoporosis: the link between them
-
4:21
Caregivers benefit from cancer support programs, U-M study f
-
4:54
Unique treatment brings hope to some with pancreatic cancer
-
1:46
Our Global Challenge
-
3:04
Teaching hand surgery techniques to Vietnamese surgeons
-
3:49
Calm the heart to stop a stroke?
-
2:32
UMHS honored by AHA for quality, safety
-
2:26
Students for Jamaica: Hagley Gap